Neuropeptide W-23 (human)

L-Tryptophyl-L-tyrosyl-L-lysyl-L-histidyl-L-valyl-L-alanyl-L-seryl-L-prolyl-L-arginyl-L-tyrosyl-L-histidyl-L-threonyl-L-valylglycyl-L-arginyl-L-alanyl-L-alanylglycyl-L-leucyl-L-leucyl-L-methionylglycyl-L-leucine; NPW 23; 100: PN: WO03045994 SEQID: 100 unclaimed sequence; 44: PN: WO02092829 SEQID: 44 claimed sequence; 125: PN: US20060293232 PAGE: 15 unclaimed sequence; 1: PN: WO2004041301 SEQID: 1 claimed sequence; 71: PN: WO0208417 SEQID: 116 unclaimed sequence; G protein-coupled receptor 8 GPR8 ligand (human); Neuropeptide W-23; 16: PN: WO02093161 SEQID: 16 claimed sequence; 3: PN: WO0236762 SEQID: 27 claimed sequence; 78: PN: WO0244368 SEQID: 8 claimed sequence; L-Leucine, L-tryptophyl-L-tyrosyl-L-lysyl-L-histidyl-L-valyl-L-alanyl-L-seryl-L-prolyl-L-arginyl-L-tyrosyl-L-histidyl-L-threonyl-L-valylglycyl-L-arginyl-L-alanyl-L-alanylglycyl-L-leucyl-L-leucyl-L-methionylglycyl-; 4: PN: WO2004106382 SEQID: 4 claimed sequence; Peptide (human 1-23-G-protein coupled receptor 8 ligand); 477: PN: US20080312157 SEQID: 532 unclaimed sequence; 100: PN: WO02102847 SEQID: 100 unclaimed sequence; 535: PN: US20110136737 SEQID: 532 unclaimed sequence; 16: PN: WO0198494 SEQID: 16 claimed sequence; 1: PN: WO2004080485 SEQID: 1 claimed sequence; 2: PN: WO03082907 SEQID: 5 claimed sequence; Expand